- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Type 1 diabetes independent risk factor for atrial fibrillation
China: Type 1 diabetes mellitus is an independent risk factor for developing atrial fibrillation (AF), findings from a recent meta-analysis have revealed. The results were published in Diabetes Research and Clinical Practice on March 20, 2023.
This systematic review and meta-analysis of four cohort studies examined the association between type 1 diabetes and atrial fibrillation risk. Pooled results indicated that patients with type 1 diabetes had a higher AF risk than the control group. The risk was higher in female patients compared with male patients and in patients, younger than 65 years compared with those older than 65.
Atrial fibrillation and diabetes are common pathological conditions in cardiology. Also, their association is frequent; about 15% of diabetes patients have atrial fibrillation, and approx 30% of AF cases occur in diabetes patients.
Diabetes is an independent risk factor for AF, and co-existing atrial fibrillation is a co-morbidity – a risk factor for the evolution of the diabetes patient.
The association of AF with DM is a situation that enables a holistic approach to AF with patient-centred management and corresponds to the recommendations of the 2020 ESC Guideline for AF's diagnosis and management.
Against the above background, Siyu Guo, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, PR China, and colleagues aimed to elaborate on the association between type 1 diabetes mellitus and the risk of atrial fibrillation in a meta-analysis.
For this purpose, the researchers systematically searched the online databases up to August 2022 for studies related to type 1 diabetes and incidence of atrial fibrillation. The meta-analysis included a total of four cohort studies. Each study's hazard ratios (HRs) were pooled via a random-effects model.
The study led to the following findings:
- Pooled results suggested that type 1 diabetes patients had a higher AF risk (HR = 1.30) than the control group.
- The subgroup analysis found a higher AF incidence in female T1DM patients (HR = 1.50) than in male patients.
- Compared with T1DM patients over 65, those with < 65 years showed an increased risk of AF (HR = 1.45).
Our meta-analysis demonstrated that T1DM was an independent risk factor for AF development, but further studies should be performed to provide more convincing evidence.
MSc. Biotechnology
Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at  editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751